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INTRALESIONAL AND SUBLESIONAL INJECTION OF TRIAMCINOLONE ACETONIDE
FOR ORAL LICHEN PLANUS
This is a preliminary report of the dramatic response obtained by intra- and
sublesional treatment of oral lichen planus with triamcinolone acetonide
in aqueous suspension (Kenalog Parenteralg). Although the initial series
(7 patients) is small and the intermediate and long-term effects are not
yet known, the immediate beneficial results have been startling. It is hoped
that similar responses may be obtained for obscure oral inflammatory en-
tities such as erythema multiforme, pemphigoid lesions, psoriasis and
others of "unknown etiology."
Although the etiology of lichen planus is unknown, it has been suggested
that patients exhibiting oral manifestations of this disease may be cate-
gorized as nervous, anxious, or emotionally distressed. Whatever the
etiology, there has been little progress towards a cure or even significant
relief of the varying symptomatology. Although some oral lesions are pain-
less, others are uncomfortable, irritating, or "burning." Bullae often cause
severe pain, especially when ruptured, leaving raw, bleeding, sensitive
denuded areas. Unsuccessful attempts to alleviate these manifestations many
times have produced cancerophobia, compounding the emotional problems.
Past treatment regimens for oral lichen planus have been relatively in-
effective. Topical applications of synthetic corticosteroids recently have
been the vogue, and although early reports were encouraging, later results
did not support the initial enthusiasm.
Because of the effectiveness of triamcinolone acetonide aqueous suspen-
sion for many dermatologic entities, intra- and sublesional injections of
several oral lichen planus lesions were carried out with obvious, dramatic
response. Each lesion was given one dose of approximately 0.5 cc. (5 mg.)
injected in fractional amounts at various points in the lesion. Larger lesions
were given slightly more, 0.7 cc. (7 mg.). There was little to no discomfort
following the injections. After 72 hours, examination of the lesions showed
45% to 50%o involution with corresponding relief of symptoms. In three
cases the entire lesion disappeared in two weeks. In the other four cases
with larger lesions, approximately 10%o to 15%o of the lesion remained,
but the patients were completely symptom free. It has not yet been deter-
mined whether injected Kenalog® is the only drug effective in this disease,
and further tests with other medications should be carried out.
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FIG. 2. Ten days post injection, showing complete involution
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SUMMARY
To date there has been no satisfactory treatment for oral lichen planus.
The intralesional and sublesional injection of triamcinolone acetonide
aqueous suspension has produced short-term, dramatic results enhancing
the prospect of effective management of this disease.
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